Appili Therapeutics Receives Government of Canada Assistance to Support Continued Growth of its Novel Anti-Infective Pipeline


HALIFAX, Nova Scotia–(BUSINESS WIRE)–lt;a href="" target="_blank"gt;$IMVlt;/agt; lt;a href="" target="_blank"gt;#AntibioticDeveloperlt;/agt;–Pharmaceutical company Appili Therapeutics Inc. ("Appili" or the "Company") announced today that it is receiving a $476,000 CAD repayable contribution through the Atlantic Canada Opportunities Agency’s (ACOA) Regional Economic Growth through Innovation (REGI) program. Appili is creating novel antibiotic and anti-infective therapies to help patients suffering from serious infections and to address the need for new treatments due to increasing resistance to